Heart disease risk raised by common household products, study finds
In an analysis of population surveys, researchers at NYU Langone Health discovered that daily exposure to chemicals in common household items could have been a factor in more than 356,000 heart disease deaths in 2018 alone.
That number equates to more than 13% of heart disease-related deaths worldwide for people between 55 and 64 years of age.
The study, which was published in the journal Lancet eBioMedicine on April 29, explored the risks of chemicals called phthalates, which are found in cosmetics, detergents, solvents, plastic pipes, bug repellents and other products, according to an NYU press release.
In this research, the focus was a specific type of phthalate called di-2-ethylhexyl phthalate (DEHP), which is used to make softer, more flexible plastics like food containers and medical equipment, the release stated.
DEHP has been linked to inflammation in the arteries of the heart, making people more susceptible to heart attack or stroke.
To determine levels of DEHP exposure, the researchers analyzed dozens of population surveys spanning 200 countries and territories.
Mortality data was obtained from the Institute for Health Metrics and Evaluation, a research group in the U.S. that collects medical information worldwide to identify trends in public health.
"Our results underscore the urgent need for global regulations to reduce exposure to these toxins."
"By highlighting the connection between phthalates and a leading cause of death across the world, our findings add to the vast body of evidence that these chemicals present a tremendous danger to human health," said study lead author Sara Hyman, BS, an associate research scientist at NYU Grossman School of Medicine, in the release.
The regions with the highest heart disease death tolls linked to phthalates include the Middle East, South Asia, East Asia and the Pacific.
"Our results underscore the urgent need for global regulations to reduce exposure to these toxins, especially in areas most affected by rapid industrialization and plastic consumption," said senior study author Dr. Trasande, the Jim G. Hendrick, MD, professor of pediatrics at NYU Grossman School of Medicine, in the release.
Inflammation is a known cause of coronary artery disease, according to Dr. Jasdeep Dalawari, an Illinois-based interventional cardiologist and regional chief medical officer at VitalSolution, an Ingenovis Health company.
"Our bodies release chemicals and hormones that give directions to the artery to open, close or change diameter," Dalawari, who was not involved in the study, told Fox News Digital.
"This study suggests that microplastics may interfere with those internal signals, so the artery doesn't perform the way it should."
"Microplastics are widely present in a variety of products we use every day, and it's crucial to understand their long-term effects on human health," he added.
Renato Apolito, M.D., medical director of cardiac catheterization at Hackensack Meridian Jersey Shore University Medical Center, agreed that manmade plastic products have long been known and suspected to be health risks.
"These often use highly engineered chemicals where the goal is not quality and safety, but instead cost-effectiveness and convenience," Apolito, who was not involved in the study, told Fox News Digital.
The doctor shared that he stopped using non-stick pans long ago, and mostly uses glass storage and avoids eating and drinking from plastic containers.
Apolito noted, however, that the "longitudinal and observational" nature of the study comes with limitations.
"It is generally used to see if there's any correlation between exposure and health risk, which is then used to study the topic further in a more controlled fashion," Apolito, who was not involved in the study, told Fox News Digital.
"It cannot control for unidentified variations in lifestyles among the people followed."
Senior author Trasande also pointed out the potential limitations.
The analysis does not establish that DEHP caused heart disease and that higher death risks did not take into account other types of phthalates, he stated.
The study also did not include death rates in other age groups, the doctor pointed out, which means the overall death toll is "likely much higher."
Looking ahead, the researchers plan to investigate how reducing phthalate exposure affects mortality rates.
They will also measure the chemical's potential role in other health concerns.
"These studies are typically what are used to study the next step of elucidating cause and effect," Apolito said. "This can lead to the FDA and other policymakers banning or outlawing the use of such products."
"Microplastics are widely present in a variety of products we use every day, and it's crucial to understand their long-term effects on human health."
The study was funded by the National Institutes of Health.
Dalawari suggested that the researchers may want to look at other contributing factors, including air pollution, which has proven to be a "novel non-traditional risk factor" for coronary disease.
"The intersection of pollution, regulation and genetic predisposition provides a complex landscape, and further research is necessary to unravel these connections, paving the way for more informed public health policies and preventive measures," he added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Journals
an hour ago
- Business Journals
BJC Health System reaches new deal with insurer Cigna Healthcare
BJC Health System, the St. Louis-based multistate health care provider, has struck a new deal with insurer Cigna Healthcare that keeps its services in-network for patients covered by the insurer.
Newsweek
2 hours ago
- Newsweek
Moon Mining Takes Giant Leap Forward With Plans to Harvest Lunar Soil
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A Seattle-based startup wants to redefine the concept of a Harvest Moon. Interlune, launched in 2020 by former Blue Origin executives, develops excavation equipment and technology to mine the moon for an extremely valuable and rare helium isotope — and already has customers lining up for the ambitious mission, including the U.S government. Extremely Valuable, Extraordinarily Rare "At $20 million dollars a kilogram, helium-3 is only resource in the universe that is priced high enough to warrant going to space and bringing it back to Earth," Interlune cofounder and CEO Rob Meyerson told Newsweek. "And we felt like with the ability to buy services, we can make the economics work and that's where we are today." If successfully extracted from lunar soil, or regolith, where Interlune estimates up to a million metric tons is concentrated, the newfound abundance of helium-3 could revolutionize a number of industries, including quantum computing, national security and medical imaging. The scarce isotope also "holds promise" as a potential fuel source for nuclear fusion, Meyerson said. A full-scale prototype of Interlune's excavator to harvest helium-3 from the moon, developed in partnership with industrial equipment manufacturer Vermeer Corporation, was unveiled by the companies in May. A full-scale prototype of Interlune's excavator to harvest helium-3 from the moon, developed in partnership with industrial equipment manufacturer Vermeer Corporation, was unveiled by the companies in May. courtesy of Interlune "We work backwards from an aspirational vision and that vision is a fleet of five harvesters that are machines that will excavate, sort, extract and separate the helium-3 from the lunar regolith and produce tens of kilograms of helium-3 per year," he said. "It's challenging and dependent on private financing. It's also dependent on a lot of other companies." Meyerson said Interlune's quest to become the first company to commercialize natural resources from space is contingent upon continued progress at Elon Musk's SpaceX, which recently unveiled the latest design of its super heavy-lift launch vehicle, Starship, ahead of preflight testing. Musk has said he hopes to utilize the spacecraft for uncrewed missions to Mars as soon as next year, though that timeline is thought to be highly optimistic. "But I do think that we need to put challenging milestones into place," Meyerson said. "And I think it's doable." While extremely rare on Earth due to its magnetic field that blocks many charged particles from the sun, helium-3 is abundant on the moon after more than 4 million years of bombardment by solar winds. A rendering of the Interlune Harvester, which will process moon dirt, or regolith, back onto the lunar surface, which will subsequently resemble a tilled field, according to company officials. A rendering of the Interlune Harvester, which will process moon dirt, or regolith, back onto the lunar surface, which will subsequently resemble a tilled field, according to company officials. courtesy of Interlune Interlune plans a prospecting mission by the end of 2027 — aiming to launch a 50-kilogram payload to sample lunar regolith in search of helium-3, Meyerson said. "And that's the mission we're working toward," he said. "Major design progress going on within the team. We're testing hardware now and getting ready to conduct our mission." Alongside partners from Vermeer Corporation, which manufactures industrial and agricultural equipment, Interlune in early May unveiled a full-scale prototype of an excavator designed to process 100 metric tons of moon dirt per hour. Since helium-3 on the lunar surface is measured in parts per billion, continuous extraction capability is essential, Meyerson said. "We're in another cycle now where we're updating the design, so we'll have more by the end of the summer or early fall," Meyerson told Newsweek of the next upcoming iteration of its excavator. Interlune envisions harvesters, a solar power plant, a rover and return launchers as key components of its multi-year mission in search of helium-3. Interlune envisions harvesters, a solar power plant, a rover and return launchers as key components of its multi-year mission in search of helium-3. courtesy of Interlune Jason Andringa, Vermeer's president and CEO, previously worked as an engineer at NASA's Jet Propulsion Laboratory, contributing to the Curiosity Rover and other early-phase mission concepts. The burgeoning collaboration with Interlune represents an opportunity for the Iowa-based firm to take its excavation expertise to an "all-new, out-of-this-world jobsite," he said. "The engineering team at Vermeer has been energized by the challenge and we are proud of the solutions we're working on in partnership with Interlune," Andringa told Newsweek in a statement. "We look forward to being a part of this impressive project that will ultimately positively impact our world for decades to come." Customers Line Up Each harvester will be about the size of an electric car, Meyerson said. Once on the lunar surface, the machines will begin a four-step proprietary process to excavate, sort, extract and separate helium-3. Meyerson acknowledged the cost of a successful helium-3 lunar mining mission will be significant, with Interlune relying on raising equity and government grants. Some contracts have already been inked, including deals with the U.S. Department of Energy Isotope Program and Maybell Quantum, a quantum infrastructure company. An artist's rendering of a rocket with a capsule containing helium-3 headed to Earth after blasting off from the lunar surface. An artist's rendering of a rocket with a capsule containing helium-3 headed to Earth after blasting off from the lunar surface. courtesy of Interlune "We have customers that have signed contracts for future sales," Meyerson told Newsweek. "Interlune still stands alone as the only company that has contracts for the sale of space resources and that's something we can use to justify our fundraising efforts going forward." Interlune, which has raised $18 million in funding to date, announced both agreements in early May while unveiling its excavator prototype. The Department of Energy has agreed to purchase three liters of helium-3 harvested from the moon no later than April 2029. Christopher Landers, director of the Department of Energy's Office of Isotope R&D and Production, said the agency works to ensure a "healthy domestic isotope ecosystem" so the United States can remain at the forefront of evolving technologies and capabilities. The agency manages federal inventories of more than 300 isotopes, including helium-3, Landers said. Interlune's leadership team, from left: chief executive officer Rob Meyerson, chief operating officer Indra Hornsby, executive chairman Harrison Schmitt, chief technology officer Gary Lai and head of product James Antifaev. Interlune's leadership team, from left: chief executive officer Rob Meyerson, chief operating officer Indra Hornsby, executive chairman Harrison Schmitt, chief technology officer Gary Lai and head of product James Antifaev. courtesy of Interlune "Helium-3 is obviously of high importance," he said. "Helium-3 is needed in cryogenics, which is a huge driver for quantum, it's needed for fusion and there's medical applications as well. But helium-3 is really, if you break it down and look at cryogenics and fusion, is on a trajectory that's moving at an exponential rate." The contract with Interlune signals the agency's attempt to facilitate a "healthy industrial availability" of helium-3, Landers said. "This was an opportunity where if Interlune is successful, they could have a major impact in making helium-3 more readily available commercially," he added. "And then similarly, through our token contract, it can establish a relationship where we could also help ensure a stable supply for that federal reserve." Maybell Quantum, which agreed to buy thousands of liters of helium-3 for delivery between 2029 and 2035, will use the extracted isotope to chill dilution refrigerators to near-absolute zero temperatures. Solar wind has bombarded the moon with helium-3 for billions of years, but Earth's magnetosphere blocks the continual stream of charged particles. The lunar surface contains more than 1 million metric tons of the rare... Solar wind has bombarded the moon with helium-3 for billions of years, but Earth's magnetosphere blocks the continual stream of charged particles. The lunar surface contains more than 1 million metric tons of the rare isotope, Interlune estimates. More courtesy of Interlune Gary Lai, Interlune's cofounder and chief technology officer, said helium-3 represents a "rare commodity" that's extremely limited on Earth yet plentiful on the moon. The company's excavator prototype is now being fine-tuned for zero-gravity operation. "It works quite well on Earth," the former chief architect at Blue Origin told Newsweek. "Now we're designing it to operate in space, and the intention is to go on our first large harvesting space mission, which we call Harvest Moon." 'Humans Find a Way' The upcoming prospecting mission will seek to prove reliable and accessible depositories of helium-3, which are most heavily concentrated in dark regions near the moon's equator. The extracted nonflammable gas must then be cooled until it liquifies before being sent in a rocket bound for Earth, Lai said. "We're actively today in our lab — like, just 100 feet behind me — doing the first sort of groundbreaking experiments to liquify and distill helium-3 out of a mixture of regular helium," Lai said. "That's a critical technology. We have to do that not only here, but we have to build the system to do that on the moon." Interlune hopes to put a full-scale excavator on the moon by 2029, potentially providing a scalable cache of helium-3 that could produce enough clean fusion energy to power the Earth for 10,000 years, as well as immediate impact in quantum computing, national security and medical imaging, Lai told Newsweek. "When there's an abundance of any material on Earth, humans find a way to use it," he said. "It has so many unique physical properties. It has many uses and I'm pretty confident that when it is more available, people will find even more uses for it because it's such a unique isotope."
CBS News
3 hours ago
- CBS News
State investigators found Weiss Hospital lacked supplies, ran "makeshift" ER department, reports say
New details are shedding light on why the federal government revoked Weiss Memorial Hospital's access to Medicare payments last week. State records obtained by The Sun-Times showed investigators found the Uptown Hospital was using a "makeshift" emergency department in an office building. Two doctors and a nurse reportedly told state investigators that it was nearly impossible to treat patients there because it lacked medications, oxygen supplies, and monitoring equipment. The investigation also found that three patients who went to the hospital in June and July did not get the care they needed. Starting on Aug. 9, Medicare won't pay Weiss for inpatient services, which the hospital reported received over half of its 2023 revenue from the program, according to the Sun-Times. This is another setback for the hospital, which suffered a major air-conditioning system failure last month, forcing dozens of patients to be transferred to its sister institution, West Suburban Hospital in Oak Park.
